Pneumonia
- PMID: 33833230
- DOI: 10.1038/s41572-021-00259-0
Pneumonia
Abstract
Pneumonia is a common acute respiratory infection that affects the alveoli and distal airways; it is a major health problem and associated with high morbidity and short-term and long-term mortality in all age groups worldwide. Pneumonia is broadly divided into community-acquired pneumonia or hospital-acquired pneumonia. A large variety of microorganisms can cause pneumonia, including bacteria, respiratory viruses and fungi, and there are great geographical variations in their prevalence. Pneumonia occurs more commonly in susceptible individuals, including children of <5 years of age and older adults with prior chronic conditions. Development of the disease largely depends on the host immune response, with pathogen characteristics having a less prominent role. Individuals with pneumonia often present with respiratory and systemic symptoms, and diagnosis is based on both clinical presentation and radiological findings. It is crucial to identify the causative pathogens, as delayed and inadequate antimicrobial therapy can lead to poor outcomes. New antibiotic and non-antibiotic therapies, in addition to rapid and accurate diagnostic tests that can detect pathogens and antibiotic resistance will improve the management of pneumonia.
Similar articles
-
Atypical pathogen infection in community-acquired pneumonia.Biosci Trends. 2016 Feb;10(1):7-13. doi: 10.5582/bst.2016.01021. Biosci Trends. 2016. PMID: 26961211 Review.
-
Advances in molecular diagnostic tests for pneumonia.Curr Opin Pulm Med. 2020 May;26(3):241-248. doi: 10.1097/MCP.0000000000000668. Curr Opin Pulm Med. 2020. PMID: 32068574 Review.
-
CE: Community-Acquired Pneumonia: A Review of Current Diagnostic Criteria and Management.Am J Nurs. 2020 Dec;120(12):34-42. doi: 10.1097/01.NAJ.0000723420.30838.97. Am J Nurs. 2020. PMID: 33181526 Review.
-
Advances in the causes and management of community acquired pneumonia in adults.BMJ. 2017 Jul 10;358:j2471. doi: 10.1136/bmj.j2471. BMJ. 2017. PMID: 28694251 Review.
-
Severe Pneumonia.Med Clin North Am. 2025 May;109(3):705-720. doi: 10.1016/j.mcna.2024.12.011. Epub 2025 Feb 21. Med Clin North Am. 2025. PMID: 40185557 Review.
Cited by
-
Dayuan Yin alleviates symptoms of HCoV-229E-induced pneumonia and modulates the Ras/Raf1/MEK/ERK pathway.Nat Prod Bioprospect. 2024 Nov 4;14(1):58. doi: 10.1007/s13659-024-00474-8. Nat Prod Bioprospect. 2024. PMID: 39495380 Free PMC article.
-
Proteomic profiling of neutrophils and plasma in community-acquired pneumonia reveals crucial proteins in diverse biological pathways linked to clinical outcome.Front Immunol. 2024 Oct 18;15:1470383. doi: 10.3389/fimmu.2024.1470383. eCollection 2024. Front Immunol. 2024. PMID: 39493755 Free PMC article.
-
Focus on long non-coding RNA MALAT1: Insights into acute and chronic lung diseases.Front Genet. 2022 Sep 16;13:1003964. doi: 10.3389/fgene.2022.1003964. eCollection 2022. Front Genet. 2022. PMID: 36186445 Free PMC article. Review.
-
Acute Effects of Low Temperatures and Cold Waves on Elderly Infectious Pneumonia Mortality - Jinan City, Shandong Province, China, 2014-2022.China CDC Wkly. 2024 Feb 2;6(5):77-82. doi: 10.46234/ccdcw2024.017. China CDC Wkly. 2024. PMID: 38410531 Free PMC article.
-
Selective CB2 Receptor Agonist, HU-308, Reduces Systemic Inflammation in Endotoxin Model of Pneumonia-Induced Acute Lung Injury.Int J Mol Sci. 2022 Dec 13;23(24):15857. doi: 10.3390/ijms232415857. Int J Mol Sci. 2022. PMID: 36555499 Free PMC article.
References
-
- Mandell, L. A. & Niederman, M. S. Aspiration pneumonia. N. Engl. J. Med. 380, 651–663 (2019). A review article about aspiration pneumonia, including new insights about microbial aetiology and antibiotic treatment.
-
- Cillóniz, C. et al. Microbial aetiology of community-acquired pneumonia and its relation to severity. Thorax 66, 340–346 (2011).
-
- Torres, A. et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia. Eur. Respir. J. 50, 1700582 (2017). In these international European and Latin American guidelines, a panel of experts present recommendations about diagnosis, risk factor for antibiotic resistance and type and duration of treatment for HAP and VAP. PICO questions and GRADE methodology were used.
-
- Kalil, A. C. et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin. Infect. Dis. 63, e61–e111 (2016). These guidelines provide risk factors for suspected MDR or XDR microorganisms and recommendations for empirical treatments, use of biomarkers and duration of antibiotic administration. - PubMed - PMC
-
- Metlay, J. P. et al. Diagnosis and treatment of adults with community-acquired pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America. Am. J. Respir. Crit. Care Med. 200, e45–e67 (2019). These guidelines include new recommendations for microbiological diagnostic tests, in particular for empirical treatments in outside and in-hospital patients. - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical